We are monitoring the impact of COVID-19 on Dendritic Cell Cancer Vaccines Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5265
Share on
Share on

Global Dendritic Cell Cancer Vaccines Market Size, Share, Trends and Growth Analysis Report – Segmented By Product Type, End User and Region - Industry Forecast | 2019 to 2024

Pulished: February, 2020
ID: 5265
Pages: 175

Industry Analysis

As per the report, the size of the global dendritic cell cancer vaccines market is forecasted to grow at a robust CAGR from 2019 to 2024.

Human tumours express several protein antigens that can be recognized by T cells; thus, it provides potential targets for cancer therapy. Dendritic cells are rare leukocytes that are uniquely potent in their ability to present antigen to the T cells, according to WHO around 9.6 million people died in the year 2018. Also, about 300000 cases were detected in the children of the age 0 – 19 years. The isolated dendritic cells are loaded with tumour antigen ex vivo. They are administrated as a cellular vaccine and been found to induce protective and therapeutic anti-tumour immunity during the experiment. 

MARKET DRIVERS

Growing incidence of cancer across the world is majorly propelling the market growth. Raising funds for the development of new vaccine-related to disease from the public and private organizations is boosting the market growth. The allogeneic dendritic cells are used to create a vaccine for COVID-19. On-going research on the development of vaccines to cure tumour cells is escalating the demand of the market. Increasing disposable income in developed and developing countries is levelling up the growth rate of the market. 

MARKET RESTRAINTS

Lack of knowledge over the utilization of vaccines in various forms is slowly degrading the demand of the market. Stringent rules and regulations by the government is also a factor impeding the need of the dendritic cell vaccines market. The shortage of skilled professionals in the research centres is also limiting the growth rate of the market. 

RECENT MARKET DEVELOPMENTS

  • On May 5 2020, Lineage Cell Therapeutics Inc. developed a vaccine for COVID – 19 with the help of allogeneic dendritic cell.
  • On June 2, 2020, NW Biotherapeutics Inc. developed DCVax personalized immune therapy for solid tumour cancers (glioblastoma brain cancer). It has entered the III phase of the clinical trial. 
  • On May 18 2020, OSE Immunotherapeutic announced that new preclinical data identified a novel myeloid immune checkpoint target for cancer immunotherapy.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 to 2024

Base Year

2018

Forecast Period

2019 to 2024

Segments Covered

By Product Type, End-User and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This market research report on Global Dendritic Cell Cancer Vaccines Market has been segmented based on the product type, end-user and region.

Dendritic Cell Cancer Vaccines Market - By Product Type:

  • CreaVax
  • Sipuleucel-T (Provenge)

Based on product type, the Provenge was the first DC vaccine which was introduced in the market. So naturally, it follows that it is the market leader and is expected to remain so until the end of the forecast period. It treats melanoma, prostate cancer etc. It was approved by the FDA nearly seven years ago.

Dendritic Cell Cancer Vaccines Market - By End User:

  • Paediatrics
  • Adults

Dendritic Cell Cancer Vaccines Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, North American captured the highest share in the global market. The United States leads the market in North America. Europe is not far behind and is expected to close in on the North American market in the forecast mentioned above period. The UK is the market leader in this region.

The Asia Pacific will continue its high growth spurt until 2024. Booming economies of India and China are spearheading this spectacular growth. Latin America and MEA continue to lag and will remain the least attractive markets all through the forecast period.

TOP COMPANIES IN THE MARKET

Key market participants leading the global dendritic cell cancer vaccines market profiled in the report are 3M Company, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime, Sanpower Corporation, Elios Therapeutics, ImmunoCellular Therapeutics, Immunicum, Kiromic, Medigene and Merck & Co.

1. Introduction       

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                 

                2.1 Introduction     

                2.2 Research Phases                      

      2.2.1 Secondary Research           

      2.2.2 Primary Research 

      2.2.3 Econometric Modelling      

      2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline

3. Overview             

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)          

                4.1 Market Drivers

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market    

5. Market Segmentation                    

                5.1 Product Type   

      5.1.1 Introduction           

      5.1.2 CreaVax   

      5.1.3 Sipuleucel-T (Provenge)    

      5.1.4 Others      

      5.1.5  Y-o-Y Growth Analysis, By Product Type   

      5.1.6  Market Attractiveness Analysis, By Product Type 

      5.1.7  Market Share Analysis, By Product Type   

                5.2 End User                      

      5.2.1 Introduction           

      5.2.2 Pediatrics 

      5.2.3 Adults       

      5.2.4 Y-o-Y Growth Analysis, By End User             

      5.2.5 Market Attractiveness Analysis, By End User           

      5.2.6 Market Share Analysis, By End User             

6. Geographical Analysis                    

                6.1 Introduction     

      6.1.1 Regional Trends    

      6.1.2 Impact Analysis     

      6.1.3 Y-o-Y Growth Analysis        

                      6.1.3.1 By Geographical Area

                      6.1.3.2 By Product Type

                      6.1.3.3 By End User

      6.1.4  Market Attractiveness Analysis     

                      6.1.4.1 By Geographical Area

                      6.1.4.2 By Product Type

                      6.1.4.3 By End User

      6.1.5  Market Share Analysis      

                      6.1.5.1 By Geographical Area

                      6.1.5.2 By Product Type

                      6.1.5.3 By End User

                6.2 North America                          

      6.1.1 Introduction           

      6.1.2 United States         

      6.1.3 Canada     

                6.3 Europe                         

      6.2.1 Introduction           

      6.2.2 U.K             

      6.2.3 Spain         

      6.2.4 Germany 

      6.2.5 Italy            

      6.2.6 France       

                6.4 Asia-Pacific                 

      6.3.1 Introduction           

      6.3.2 China         

      6.3.3 India          

      6.3.4 Japan         

      6.3.5 Australia   

      6.3.6 South Korea           

                6.5 Latin America   

      6.4.1 Introduction           

      6.4.2 Brazil          

      6.4.3 Argentina

      6.4.4 Mexico     

      6.4.5 Rest of Latin America          

                6.6 Middle East & Africa     

      6.5.1 Introduction           

      6.5.2 Middle-East            

      6.5.3 Africa         

7. Strategic Analysis             

                7.1 PESTLE analysis                         

      7.1.1 Political     

      7.1.2 Economic 

      7.1.3 Social         

      7.1.4 Technological         

      7.1.5 Legal          

      7.1.6 Environmental       

                7.2 Porter’s Five analysis    

      7.2.1 Bargaining Power of Suppliers        

      7.2.2 Bargaining Power of Consumers    

      7.2.3 Threat of New Entrants     

      7.2.4 Threat of Substitute Products and Services              

      7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis              

                8.1 3M Company   

      8.1.1 Overview 

      8.1.2 Product Analysis   

      8.1.3 Financial analysis  

      8.1.4 Recent Developments       

      8.1.5 SWOT analysis       

      8.1.6 Analyst View          

                8.2 Activarti                       

                8.3 Argos Therapeutics                 

                8.4 Batavia Bioservices                  

                8.5 Bellicum Pharmaceuticals                     

                8.6 Creagene                    

                8.7 DanDrit Biotech                        

                8.8 DCPrime                      

                8.9 Sanpower Corporation (Dendreon Corporation)                        

                8.10 Elios Therapeutics                 

9. Competitive Landscape                 

                9.1 Market share analysis  

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities               

Appendix                 

                a) List of Tables                

                b) List of Figures    

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Dendritic Cell Cancer Vaccines Market By Region, From 2019-2024 ( USD Million )
  2. Global Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  3. Global CreaVDendritic Cell Cancerax Market By Region, From 2019-2024 ( USD Million )
  4. Global Sipuleucel-T (Provenge) Market By Region, From 2019-2024 ( USD Million )
  5. Global Others Market By Region, From 2019-2024 ( USD Million )
  6. Global Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  7. Global Pediatrics Market By Region, From 2019-2024 ( USD Million )
  8. Global Adults Market By Region, From 2019-2024 ( USD Million )
  9. North America Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  10. North America CreaVax Market By Region, From 2019-2024 ( USD Million )
  11. North America Sipuleucel-T (Provenge) Market By Region, From 2019-2024 ( USD Million )
  12. North America Others Market By Region, From 2019-2024 ( USD Million )
  13. North America Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  14. North America Pediatrics Market By Region, From 2019-2024 ( USD Million )
  15. North America Adults Market By Region, From 2019-2024 ( USD Million )
  16. United States Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  17. United States Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  18. Canada Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  19. Canada Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  20. Europe Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  21. Europe CreaVax Market By Region, From 2019-2024 ( USD Million )
  22. Europe Sipuleucel-T (Provenge) Market By Region, From 2019-2024 ( USD Million )
  23. Europe Others Market By Region, From 2019-2024 ( USD Million )
  24. Europe Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  25. Europe Pediatrics Market By Region, From 2019-2024 ( USD Million )
  26. Europe Adults Market By Region, From 2019-2024 ( USD Million )
  27. U.K. Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  28. U.K. Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  29. Germany Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  30. Germany Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  31. France Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  32. France Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  33. Italy Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  34. Italy Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  35. Spain Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  36. Spain Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  37. Asia Pacific Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  38. Asia Pacific CreaVax Market By Region, From 2019-2024 ( USD Million )
  39. Asia Pacific Sipuleucel-T (Provenge) Market By Region, From 2019-2024 ( USD Million )
  40. Asia Pacific Others Market By Region, From 2019-2024 ( USD Million )
  41. Asia Pacific Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  42. Asia Pacific Pediatrics Market By Region, From 2019-2024 ( USD Million )
  43. Asia Pacific Adults Market By Region, From 2019-2024 ( USD Million )
  44. Japan Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  45. Japan Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  46. China Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  47. China Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  48. India Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  49. India Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  50. Australia Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  51. Australia Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  52. South Korea Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  53. South Korea Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  54. Latin America Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  55. Latin America CreaVax Market By Region, From 2019-2024 ( USD Million )
  56. Latin America Sipuleucel-T (Provenge) Market By Region, From 2019-2024 ( USD Million )
  57. Latin America Others Market By Region, From 2019-2024 ( USD Million )
  58. Latin America Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  59. Latin America Pediatrics Market By Region, From 2019-2024 ( USD Million )
  60. Latin America Adults Market By Region, From 2019-2024 ( USD Million )
  61. Brazil Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  62. Brazil Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  63. Argentina Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  64. Argentina Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  65. Mexico Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  66. Mexico Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  67. Rest of Latin America Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  68. Rest of Latin America Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  69. Middle East and Africa Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  70. Middle East and Africa CreaVax Market By Region, From 2019-2024 ( USD Million )
  71. Middle East and Africa Sipuleucel-T (Provenge) Market By Region, From 2019-2024 ( USD Million )
  72. Middle East and Africa Others Market By Region, From 2019-2024 ( USD Million )
  73. Middle East and Africa Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  74. Middle East and Africa Pediatrics Market By Region, From 2019-2024 ( USD Million )
  75. Middle East and Africa Adults Market By Region, From 2019-2024 ( USD Million )
  76. Middle East Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  77. Middle East Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )
  78. Africa Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Million )
  79. Africa Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample